Theralase Technologies Inc.
TLT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.58% | 17.03% | 11.81% | -28.98% | 3.80% |
| Total Depreciation and Amortization | -2.20% | 2.04% | -2.77% | -4.36% | -1.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.98% | 38.99% | -44.36% | 4.23% | -12.96% |
| Change in Net Operating Assets | 130.67% | -208.52% | 1,328.07% | 90.22% | -358.01% |
| Cash from Operations | 67.51% | -239.20% | 63.40% | 11.63% | -106.79% |
| Capital Expenditure | 22.22% | -950.00% | 77.78% | 67.86% | -3.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 22.22% | -950.00% | 77.78% | 67.86% | -3.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -104.26% | -2.17% | -1.77% | 57.12% | -140.64% |
| Issuance of Common Stock | -65.24% | 75.48% | -37.46% | 6.14% | 146.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -69.31% | 78.44% | -39.13% | 10.25% | 142.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.14% | -131.60% | 338.62% | 137.22% | -9.42% |
